SCI & TECH● LOW2d ago · Aug 30, 2026, 8:01 PM
Bayer’s AskBio completes enrollment in Phase 2 heart failure gene therapy trial
Seeking Alpha Tech · global
Bayer's AskBio has successfully completed patient enrollment for its Phase 2 clinical trial of a gene therapy for heart failure. This marks a significant step in the development of a potential new medical treatment.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Sci & Tech
SCI & TECH35m agoFor a national science library in ColombiaLa Silla VacíaSCI & TECH45m agoCochin University of Science and Technology decides to introduce industry-flexible curriculumThe HinduSCI & TECH1h agoFrontier AI at a cost: what Anthropic’s Fable 5.1 means for the US-China model raceSouth China Morning PostSCI & TECH1h agoNvidia Put $2 Billion Into Coherent. Is Optical Bandwidth the Next AI Bottleneck?Yahoo Finance